Humaid Al-Shamsi, CEO of Burjeel Cancer Institute and Chairman of Nexomic, shared on LinkedIn:
“Wrapping up two impactful days in Alexandria, Egypt at ALIGN 2026 – Advancing Learning, Innovation and Gynecologic Oncology Network , organized by the Emirates Oncology Society – bringing together experts from across the region for meaningful scientific exchange and dialogue on the evolving landscape of gynaecologic cancer care.
In collaboration between Emirates Oncology Society with the Egyptian Gynecologic Oncology Society (EGOS), ALIGN provided a valuable platform for shared learning, exchange of expertise, and translating evolving evidence into clinical practice.
Thank you dear friend Emad Shash for your support as always.
Thank you to GSK for the valued partnership. We look forward to continuing our collaboration in the future.
Thank you to Rasha Abou Ali and Ahmed Tarek for your professional support and paying attention to every single small detail.
Thank you Conveners for the outstanding organization.”
Other articles featuring Humaid Al-Shamsi on OncoDaily.
